Abstract

This study investigated subfertile patients with abnormally thin endometrium after infertility treatment. As they had adequate serum concentrations of hormones, an endometrial factor for subfertility was suspected. To elucidate the cause of subfertility, endometrial biopsies were taken in each patient in the late proliferative and mid-secretory phases of one menstrual cycle. Endometrial biopsies from women with normal menstrual cycles and confirmed fertility who were undergoing hysterectomy for benign uterine disease were used as positive controls. The tissue samples were investigated for steroid hormone receptor expression and for the proliferation marker Ki-67. Immunohistochemistry was performed with antibodies against the marker molecules for endometrial receptivity - β 3 integrin, VEGF, LIF, and CD56 (large granular lymphocytes, LGLs). The steroid hormone receptors for estrogen (E2) and progesterone (P) were expressed normally (at the first biopsy) and were down-regulated (at the second biopsy) within the cycle. Strikingly, all of the marker molecules investigated showed negative or weak and inadequate expression in the mid-secretory phase. Numbers of LGLs remained as low as in the proliferative phase. In contrast, fertile patients were found to express these marker molecules distinctly in the mid-secretory phase. It may be hypothesized that a severe deficiency of these angiogenesis-related marker molecules leads to defective development of the endometrium, which remains thin. Deficient angiogenetic development may thus provide an explanation for the endometrial factor that causes infertility. Further investigations will need to focus on identifying the regulating factors that act between steroid receptor activation and the expression of these marker molecules.

Highlights

  • This study investigated subfertile patients with abnormally thin endometrium after infertility treatment

  • It may be hypothesized that a severe deficiency of these angiogenesis-related marker molecules leads to defective development of the endometrium, which remains thin

  • Biopsies taken during the proliferative phase were deficient for vascular endothelial growth factor (VEGF) and leptin receptor, these markers are expressed in normal proliferative endometrium in fertile women

Read more

Summary

Introduction

This study investigated subfertile patients with abnormally thin endometrium after infertility treatment. Marker molecules for endometrial receptivity are thought to be involved in endometrial function and in the regulation of implantation These markers include receptors such as αvβ integrin [1, 2] and the leptin receptor (OB‐Rb) [3, 4], and cytokines such as leukemia inhibitory factor (LIF) [2, 5] and vascular endothelial growth factor (VEGF) [6,7,8]. The relevance of these molecules for the implantation process has been investigated in animal models. An absence of LIF or OB‐Rb leads to sterility in female mice [9, 10]

Methods
Findings
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.